The Global Companion Animal Arthritis Market size is expected to reach $3.7 billion by 2028, rising at a market growth of 6.1% CAGR during the forecast period.
Osteoarthritis (OA) is a complicated disorder that involves joint deterioration and inflammation. The Greek words osteo, arthro, and itis are combined to form the word osteoarthritis. Osteo refers to bone, arthro means joint, while itis defines inflammation. Dogs with OA endure discomfort and inflammation in a number of joints, which makes it difficult for them to go about their daily lives. A comprehensive physical examination, palpation (using the fingers to localize and rate the level of pain), and further diagnostics such as x-rays or other imaging techniques are used to diagnose OA.
A slick material called cartilage serves as a divider or cushion between the bones within a joint. It makes it painless for the bones to move around or over one another. When a joint's cartilage suffers damage, arthritis develops. An arthritic joint eventually becomes painfully inflamed. In humans, there are about 100 different kinds of arthritis. Osteoarthritis, also referred to as a degenerative joint disease, is the most prevalent type in animals. Rheumatoid arthritis and septic arthritis, which are brought on by joint infection, are further forms. Animals that are older or middle-aged frequently get arthritis. However, these age groups are not the only ones affected by the ailment and younger animals can also contract it.
Changes in the animal's behavior, which are the main symptoms of the disease, frequently become obvious when arthritis eventually produces changes in the joint that result in discomfort. Due to the fact that arthritis frequently worsens with age, pet owners can misinterpret behavioral changes in their animals for age-related changes, such as a downturn in energy while in reality, the animal may be experiencing rather severe arthritis pain.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Elanco Animal Health, Inc., Zoetis, Inc., Vetoquinol SA, Virbac, Ceva Santé Animale, Eltech K-Laser s.r.l., Norbrook Laboratories Limited, and NexGen Pharmaceuticals, LLC.
Osteoarthritis (OA) is a complicated disorder that involves joint deterioration and inflammation. The Greek words osteo, arthro, and itis are combined to form the word osteoarthritis. Osteo refers to bone, arthro means joint, while itis defines inflammation. Dogs with OA endure discomfort and inflammation in a number of joints, which makes it difficult for them to go about their daily lives. A comprehensive physical examination, palpation (using the fingers to localize and rate the level of pain), and further diagnostics such as x-rays or other imaging techniques are used to diagnose OA.
A slick material called cartilage serves as a divider or cushion between the bones within a joint. It makes it painless for the bones to move around or over one another. When a joint's cartilage suffers damage, arthritis develops. An arthritic joint eventually becomes painfully inflamed. In humans, there are about 100 different kinds of arthritis. Osteoarthritis, also referred to as a degenerative joint disease, is the most prevalent type in animals. Rheumatoid arthritis and septic arthritis, which are brought on by joint infection, are further forms. Animals that are older or middle-aged frequently get arthritis. However, these age groups are not the only ones affected by the ailment and younger animals can also contract it.
Changes in the animal's behavior, which are the main symptoms of the disease, frequently become obvious when arthritis eventually produces changes in the joint that result in discomfort. Due to the fact that arthritis frequently worsens with age, pet owners can misinterpret behavioral changes in their animals for age-related changes, such as a downturn in energy while in reality, the animal may be experiencing rather severe arthritis pain.
COVID-19 Impact Analysis
The COVID-19 has significantly affected the companion animal arthritis market. The lockdown declarations in several nations, as well as the corresponding limited access and closure of veterinary facilities, are primarily responsible for this detrimental impact. Due to the cancellation and reduction of veterinarian appointments, the pandemic has made it more difficult for pet owners to receive adequate veterinary treatment. Due to the instability of distribution routes, the major market players have encountered severe hurdles in maintaining the supply of veterinary products.Market Growth Factors
Rising Trend Of Pet Adoption
Animals can function professionally to promote health. Numerous studies found that having a dog around promotes human socialization. Courtroom or service dogs facilitate testimony from abuse victims who have been abused as children or adults by reducing their stress levels and sympathetic nervous system arousal. In a similar way, having pets can encourage kids to engage more in social activities while also fostering more empathy and self-esteem. Other assistance animals give their owners more freedom and provide similar advantages. Pets can improve the mental condition, the sense of security and comfort, and even an optimistic attitude in the life of a person.
Increasing Number Of Initiatives To Boost Animal Welfare
Animal abuse is rapidly growing in concern as a global issue. Animal conservation is becoming more and more popular. Additionally, a sizable number of activities are being undertaken by numerous people and non-governmental groups. Additionally, a large number of organizations are being established to conserve animals. The World Animal Protection organization, for instance, is formed to regulate animal abuse. Many people are developing animal sensitivity as a result of this. People throughout the world are being inspired by these campaigns to help numerous households and stray animals.Market Restraining Factors
Side Effects Of Medications Used To Treat The Disease
The diffusion of animal arthritis is very rapid. Degenerative joint disease, also known as osteoarthritis, is the most prevalent type. Between bones, joints typically provide supple connections and protective padding. Osteoarthritis leads to bony growths inside the joint as well as fluid buildup and cartilage thinning in the joints. This may result in pain, degeneration of the joints, and decreased mobility over time. In order to treat this, a considerable number of drugs are being introduced to the market. However, these anti-inflammatory medicines have a number of side effects on the animal.Animal Type Outlook
On the basis of Animal Type, the Companion Animal Arthritis Market is segmented into Dogs, Cats, and Others. In 2021, the cats segment garnered a significant revenue share of the companion animal arthritis market. The rapidly increasing growth of the segment is primarily owing to the growing awareness among pet parents of the symptoms of cat arthritis. Another element accelerating the segment's growth is the rising incidence of osteoarthritis in the cat population. Arthritis affects a considerable number of cats, regardless of age.Indication Outlook
Based on the Indication, the Companion Animal Arthritis Market is bifurcated into Osteoarthritis and Other Arthritis. In 2021, the osteoarthritis segment procured the biggest revenue share of the companion animal arthritis market. This is due to the high number of companion animals who have osteoarthritis diagnoses. A very big number of dogs are at risk of developing osteoarthritis due to their alteration in eating habits of them. The clinical symptoms of this illness, which include despondency, weight loss, and the inability to jump or move aggressively, are also present in cats. Hence, the growth of the segment is surging.Treatment Outlook
By Treatment, the Companion Animal Arthritis Market is segregated into Medication, Supplements, and Other Treatment. In 2021, the other treatment segment recorded a substantial revenue share of the companion animal arthritis market. The quality of life for companion animals with arthritis is being considerably improved by additional treatments such as rehabilitation, lifestyle modification, and new drugs. When medication is unable to control the arthritis ailment in companion animals, surgical options are investigated. Joint replacement, joint fusion, or surgical excision of the damaged joint are the most frequent surgical treatments..Distribution Channel Outlook
On the basis of Distribution Channel, the Companion Animal Arthritis Market is classified into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Stores, and Others. In 2021. The retail pharmacies segment acquired a substantial revenue share of the companion animal arthritis market. The rising growth of the segment is attributed to the surge in the number of retail pharmacies all over the world. As the trend of adopting companion animals is increasing, various pharmacies are selling drugs for the treatment of animals. This factor is driving the growth of this segment.Regional Outlook
Region-Wise, the Companion Animal Arthritis Market is analyzed across North America, Europe, Asia-pacific, and LAMEA. In 2021, North America accounted for the largest revenue share of the companion animal arthritis market. This is a result of the major presence of key market players, the adoption of various tactics developed by major businesses to improve market penetration, the rising availability of treatment, the rising rates of diagnostics, the rising number of pets, and the rising cost of pet ownership.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Elanco Animal Health, Inc., Zoetis, Inc., Vetoquinol SA, Virbac, Ceva Santé Animale, Eltech K-Laser s.r.l., Norbrook Laboratories Limited, and NexGen Pharmaceuticals, LLC.
Scope of the Study
Market Segments Covered in the Report:
By Indication
- Osteoarthritis
- Other Arthritis
By Distribution Channel
- Veterinary Hospitals & Clinics
- Retail Pharmacies
- Online Stores
- Others
By Treatment
- Medication
- Supplements
- Other Treatment
By Animal Type
- Dogs
- Cats
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Boehringer Ingelheim International GmbH
- Dechra Pharmaceuticals PLC
- Elanco Animal Health, Inc.
- Zoetis, Inc.
- Vetoquinol SA
- Virbac
- Ceva Santé Animale
- Eltech K-Laser s.r.l.
- Norbrook Laboratories Limited
- NexGen Pharmaceuticals, LLC
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Global Companion Animal Arthritis Market by Indication
Chapter 4. Global Companion Animal Arthritis Market by Distribution Channel
Chapter 5. Global Companion Animal Arthritis Market by Treatment
Chapter 6. Global Companion Animal Arthritis Market by Animal Type
Chapter 7. Global Companion Animal Arthritis Market by Region
Chapter 8. Company Profiles
Companies Mentioned
- Boehringer Ingelheim International GmbH
- Dechra Pharmaceuticals PLC
- Elanco Animal Health, Inc.
- Zoetis, Inc.
- Vetoquinol SA
- Virbac
- Ceva Santé Animale
- Eltech K-Laser s.r.l.
- Norbrook Laboratories Limited
- NexGen Pharmaceuticals, LLC
Methodology
LOADING...
